Brief: Pixium Vision: Positive Follow-Up Data From French Trial Of Prima System
March 31 (Reuters) - Pixium Vision SA ALPIX.PA
* ANNOUNCES POSITIVE FOLLOW-UP DATA FROM FRENCH FEASIBILITY
TRIAL
OF PRIMA SYSTEM IN PATIENTS WITH DRY AGE-RELATED MACULAR
DEGENERATION (AMD)
Source text for Eikon: ID:nGNE2KP7cf
Further company coverage: PIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow